Ph.D. in population health, The University of Queensland, Australia; Grad. Cert. in health economics, The University of Queensland, Australia; B.Sc.(Hons) in genetics, The University of Queensland, Australia; B.A. in history, The University of Queensland, Australia
This researcher is available for interviews.
To arrange an interview, contact RAND Europe Media Relations at +44 (1223) 353 329, x2560, or email europeanmedia@rand.org.
More ExpertsKate Morley (she/her) is a senior research leader at RAND Europe in the Health and Wellbeing Research Group. Prior to joining RAND in 2019, Morley spent over 15 years conducting health and medical research in the academic sector in both Australia and the United Kingdom. This included post-doctoral positions at the University of Melbourne, Wellcome Trust Sanger Institute, and University College London, and a faculty position at King’s College London Institute of Psychiatry, Psychology, and Neuroscience (IOPPN). She maintains honorary appointments at IOPPN and the Centre for Epidemiology and Biostatistics at the Melbourne School of Population and Global Health, the University of Melbourne.
Morley has a background in epidemiology and biostatistics, and in-depth understanding of a broad range of quantitative and qualitative research methodology, both from her own empirical research and from designing and delivering post-graduate methodology courses. She researches the intersection between mental health care and other sectors (e.g. criminal justice, transport). Recent research includes: substance use by people detained under the Mental Health Act, the impact of Liaison and Diversion services, and physical health inequalities of people who use illicit drugs. However, she is broadly interested in the use of cross-sector data linkage approaches for health services research and the evaluation of complex interventions. Morley holds a Ph.D. in population health, Grad. Cert. in health economics, B.Sc. (Hons) in genetics, and B.A. in history.
Rodriguez-Rincon, Daniela, Sarah Parkinson, Lucy Hocking, Hamish Evans, Emma Hudson, and Katherine I. Morley, Assessing the impact of developments in genetic testing on insurers' risk exposure, RAND Corporation (RR-A1209-1), 2022
Disley, Emma, Evangelos Gkousis, Shann Hulme, Katherine I. Morley, Jack Pollard, Catherine L. Saunders, Jon Sussex, and Alex Sutherland, Outcome Evaluation of the National Model for Liaison and Diversion, RAND Corporation (RR-A1271-1), 2021
Kalk NJ, Kelleher MJ, Curtis V, Morley KI, "Addressing substance misuse: a missed opportunity in suicide prevention," Addiction, 114(3), 2019
Morley KI, Ferris J, Winstock AR, Lynskey MT, "Polysubstance use and misuse and abuse of prescription opioid analgesics: A multi-level analysis of international data," Pain, 158(6), 2017
Hall WD, Patton G, Stockings E, Weier M, Lynskey M, Morley KI, Degenhardt L, "Why young people's substance use matters for global health," Lancet Psychiatry, 3(3), 2016
Stockings E, Hall WD, Lynskey M, Morley KI, Reavley N, Strang J, Patton G, Degenhardt L, "Prevention, early intervention, harm reduction, and treatment of substance use in young people," Lancet Psychiatry, 3(3), 2016
Morley KI, Lynskey MT, Moran P, Borschmann R, Winstock A, "Polysubstance use, mental health, and high-risk behaviour: Results from the 2012 Global Drug Survey," Drug and Alcohol Review, 34(4), 2015
Lewer, D., Tweed, E.J., Aldridge, R.W., Morley, K.I., "Causes of hospital admission and mortality among people who use heroin: a cohort study comparing relative and absolute risks," Alcohol and Drug Dependence, 2019 (forthcoming)
